ATE476176T1 - Wachsähnliches material enthaltende tabletten mit verzögerter freisetzung - Google Patents
Wachsähnliches material enthaltende tabletten mit verzögerter freisetzungInfo
- Publication number
- ATE476176T1 ATE476176T1 AT08743631T AT08743631T ATE476176T1 AT E476176 T1 ATE476176 T1 AT E476176T1 AT 08743631 T AT08743631 T AT 08743631T AT 08743631 T AT08743631 T AT 08743631T AT E476176 T1 ATE476176 T1 AT E476176T1
- Authority
- AT
- Austria
- Prior art keywords
- sustained
- tablets containing
- release tablets
- containing wax
- pellets
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/90—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having two or more relevant hetero rings, condensed among themselves or with a common carbocyclic ring system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7008—Compounds having an amino group directly attached to a carbon atom of the saccharide radical, e.g. D-galactosamine, ranimustine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/14—Ectoparasiticides, e.g. scabicides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US90445607P | 2007-03-02 | 2007-03-02 | |
PCT/US2008/055534 WO2008109462A2 (en) | 2007-03-02 | 2008-02-29 | Sustained release pellets comprising wax-like material |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE476176T1 true ATE476176T1 (de) | 2010-08-15 |
Family
ID=39649304
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT08743631T ATE476176T1 (de) | 2007-03-02 | 2008-02-29 | Wachsähnliches material enthaltende tabletten mit verzögerter freisetzung |
Country Status (11)
Country | Link |
---|---|
US (2) | US10888521B2 (de) |
EP (1) | EP2144599B1 (de) |
JP (3) | JP5452236B2 (de) |
CN (1) | CN101652128B (de) |
AT (1) | ATE476176T1 (de) |
AU (1) | AU2008223091B2 (de) |
CA (1) | CA2678367C (de) |
DE (1) | DE602008002073D1 (de) |
ES (1) | ES2350029T3 (de) |
HK (1) | HK1141441A1 (de) |
WO (1) | WO2008109462A2 (de) |
Families Citing this family (84)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7776314B2 (en) | 2002-06-17 | 2010-08-17 | Grunenthal Gmbh | Abuse-proofed dosage system |
DE102005005446A1 (de) | 2005-02-04 | 2006-08-10 | Grünenthal GmbH | Bruchfeste Darreichungsformen mit retardierter Freisetzung |
DE10361596A1 (de) | 2003-12-24 | 2005-09-29 | Grünenthal GmbH | Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform |
US20070048228A1 (en) | 2003-08-06 | 2007-03-01 | Elisabeth Arkenau-Maric | Abuse-proofed dosage form |
DE10336400A1 (de) | 2003-08-06 | 2005-03-24 | Grünenthal GmbH | Gegen Missbrauch gesicherte Darreichungsform |
DE102004032049A1 (de) | 2004-07-01 | 2006-01-19 | Grünenthal GmbH | Gegen Missbrauch gesicherte, orale Darreichungsform |
DE102005005449A1 (de) | 2005-02-04 | 2006-08-10 | Grünenthal GmbH | Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform |
DE102007011485A1 (de) | 2007-03-07 | 2008-09-11 | Grünenthal GmbH | Darreichungsform mit erschwertem Missbrauch |
ITPD20070274A1 (it) * | 2007-08-08 | 2009-02-09 | Sanypet S P A | Crocchetta per animali e metodo per la sua produzione |
TWI454288B (zh) | 2008-01-25 | 2014-10-01 | Gruenenthal Chemie | 藥物劑型 |
SI2273983T1 (sl) | 2008-05-09 | 2016-11-30 | Gruenenthal Gmbh | Postopek za pripravo intermediatne praškaste formulacije in končne trdne odmerne oblike z uporabo stopnje strjevanja z razprševanjem |
JP2012533585A (ja) | 2009-07-22 | 2012-12-27 | グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング | 酸化感受性オピオイドのための不正使用防止剤形 |
JP5667183B2 (ja) | 2009-07-22 | 2015-02-12 | グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング | 加熱溶融押出成型した制御放出性投与剤型 |
WO2011080570A2 (en) * | 2009-12-29 | 2011-07-07 | Micro Labs Limited | Extended release pharmaceutical composition comprising linezolid and process for preparing the same |
US9579285B2 (en) | 2010-02-03 | 2017-02-28 | Gruenenthal Gmbh | Preparation of a powdery pharmaceutical composition by means of an extruder |
IT1398321B1 (it) * | 2010-02-26 | 2013-02-22 | Formevet Spa Ora Formevet Srl | Associazione tra un analgesico ad azione centrale e un antinfiammatorio inibitore selettivo della cicloossigenasi 2 per il trattamento dell'infiammazione e del dolore in campo veterinario |
US9636303B2 (en) | 2010-09-02 | 2017-05-02 | Gruenenthal Gmbh | Tamper resistant dosage form comprising an anionic polymer |
ES2486791T3 (es) | 2010-09-02 | 2014-08-19 | Grünenthal GmbH | Forma de dosificación resistente a la manipulación que comprende una sal inorgánica |
US20120107393A1 (en) * | 2010-10-29 | 2012-05-03 | University Of Tennessee Research Foundation | Pellets for Delivery of Biologically Active Substances |
SI2637668T1 (sl) | 2010-11-08 | 2016-11-30 | Albiero Ab | IBAT inhibitorji za zdravljenje jetrnih bolezni |
US20130028972A1 (en) | 2011-07-29 | 2013-01-31 | Grunenthal Gmbh | Tamper-resistant tablet providing immediate drug release |
AR087360A1 (es) | 2011-07-29 | 2014-03-19 | Gruenenthal Gmbh | Tableta a prueba de manipulacion que proporciona liberacion de farmaco inmediato |
CN102440963A (zh) * | 2011-11-29 | 2012-05-09 | 北京科信必成医药科技发展有限公司 | 一种别嘌醇缓释微丸及其制备方法 |
JP2015500241A (ja) * | 2011-12-02 | 2015-01-05 | ペガサス ラボラトリーズ インコーポレイテッド | 両親媒性脂質をベースとする徐放性組成物 |
US10722458B2 (en) | 2011-12-02 | 2020-07-28 | Pegasus Laboratories, Inc. | Amphipathic lipid-based sustained release compositions |
CN102716090B (zh) * | 2012-01-05 | 2014-07-16 | 金陵药业股份有限公司 | 一种盐酸二甲双胍缓释微丸及其制备方法 |
CN102590410A (zh) * | 2012-01-13 | 2012-07-18 | 亚宝药业太原制药有限公司 | 盐酸氨基葡萄糖胶囊的含量测定方法 |
CN102579405A (zh) * | 2012-01-17 | 2012-07-18 | 广州科的信医药技术有限公司 | 一种盐酸噻氯匹定缓释胶囊及其制备方法 |
US9642824B2 (en) | 2012-02-06 | 2017-05-09 | Innovative Med Concepts, LLC | Valaciclovir and diclofenac combination therapy for functional somatic syndromes |
BR112014019988A8 (pt) | 2012-02-28 | 2017-07-11 | Gruenenthal Gmbh | Forma de dosagem resistente a socamento compreendendo um composto farmacologicamente ativo e um polímero aniônico |
ES2692944T3 (es) * | 2012-04-18 | 2018-12-05 | Grünenthal GmbH | Forma de dosificación farmacéutica resistente a la manipulación y resistente a la descarga rápida de la dosis |
CA2871821C (en) | 2012-05-10 | 2021-01-12 | Painreform Ltd. | Depot formulations of a local anesthetic and methods for preparation thereof |
US10064945B2 (en) | 2012-05-11 | 2018-09-04 | Gruenenthal Gmbh | Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc |
CN102743341B (zh) * | 2012-07-28 | 2014-02-26 | 西安德天药业股份有限公司 | 右旋酮洛芬氨丁三醇缓释微粒及其制备方法和缓释制剂 |
CN103860551A (zh) * | 2012-12-10 | 2014-06-18 | 鲁南制药集团股份有限公司 | 含有依托度酸和***马多的药物组合物及其应用 |
WO2014191396A1 (en) | 2013-05-29 | 2014-12-04 | Grünenthal GmbH | Tamper resistant dosage form with bimodal release profile |
BR112015026549A2 (pt) | 2013-05-29 | 2017-07-25 | Gruenenthal Gmbh | forma de dosagem à prova de violação contendo uma ou mais partículas |
EP3013790A1 (de) | 2013-06-27 | 2016-05-04 | Mylan Laboratories Ltd. | Verfahren zur herstellung von nepafenac |
CN105682643B (zh) | 2013-07-12 | 2019-12-13 | 格吕伦塔尔有限公司 | 含有乙烯-醋酸乙烯酯聚合物的防篡改剂型 |
CN103432082A (zh) * | 2013-08-29 | 2013-12-11 | 江苏正大清江制药有限公司 | 氨基葡萄糖组合物及其制备方法 |
CA2931553C (en) | 2013-11-26 | 2022-01-18 | Grunenthal Gmbh | Preparation of a powdery pharmaceutical composition by means of cryo-milling |
US11813361B2 (en) | 2014-04-04 | 2023-11-14 | Pharmaquest International Center, Llp | Disintegrating monolithic modified release tablets containing quadri-layer extended release granules |
AU2015261060A1 (en) | 2014-05-12 | 2016-11-03 | Grunenthal Gmbh | Tamper resistant immediate release capsule formulation comprising Tapentadol |
AU2015266117A1 (en) | 2014-05-26 | 2016-11-24 | Grunenthal Gmbh | Multiparticles safeguarded against ethanolic dose-dumping |
KR20220082931A (ko) | 2014-06-25 | 2022-06-17 | 이에이 파마 가부시키가이샤 | 고형 제제 및 그의 착색 방지 또는 착색 감소 방법 |
MA41124A (fr) * | 2014-12-05 | 2017-10-10 | Sun Pharmaceutical Ind Ltd | Compositions en suspension à libération prolongée à rétention gastrique |
CN105982860B (zh) * | 2015-02-11 | 2020-04-14 | 北京科信必成医药科技发展有限公司 | 愈创甘油醚无水吞服掩味颗粒 |
MX2017013637A (es) | 2015-04-24 | 2018-03-08 | Gruenenthal Gmbh | Forma de dosificacion resistente a alteraciones con liberacion inmediata y resistencia contra la extraccion por solventes. |
US10842750B2 (en) | 2015-09-10 | 2020-11-24 | Grünenthal GmbH | Protecting oral overdose with abuse deterrent immediate release formulations |
US10786529B2 (en) | 2016-02-09 | 2020-09-29 | Albireo Ab | Oral cholestyramine formulation and use thereof |
US10441604B2 (en) | 2016-02-09 | 2019-10-15 | Albireo Ab | Cholestyramine pellets and methods for preparation thereof |
US10441605B2 (en) | 2016-02-09 | 2019-10-15 | Albireo Ab | Oral cholestyramine formulation and use thereof |
JP2019523275A (ja) * | 2016-07-26 | 2019-08-22 | アナンド パラチュル,ヴィヴェク | 有効成分の徐放性組成物 |
CA3033065A1 (en) | 2016-08-11 | 2018-02-15 | Adamis Pharmaceuticals Corporation | Drug compositions |
CN111032019B (zh) | 2017-08-09 | 2022-07-05 | 阿尔比里奥公司 | 考来烯胺颗粒、口服考来烯胺制剂及其用途 |
ES2938608T3 (es) | 2017-09-20 | 2023-04-13 | Tillotts Pharma Ag | Método para preparar una forma farmacéutica sólida que comprende anticuerpos mediante granulación en húmedo, extrusión y esferonización |
CN107802610B (zh) * | 2017-11-22 | 2020-10-20 | 乐普药业股份有限公司 | 一种单硝酸异山梨酯缓释片及制备方法 |
EP3720844A4 (de) | 2017-12-08 | 2021-08-11 | Adamis Pharmaceuticals Corporation | Arzneimittelzusammensetzungen |
EP3731802B1 (de) | 2017-12-29 | 2021-10-20 | Unilever Global IP Limited | Asphärische mikrokapsel |
MX2020006685A (es) | 2017-12-29 | 2021-11-18 | Unilever Ip Holdings B V | Microcápsula no esférica. |
US10793534B2 (en) | 2018-06-05 | 2020-10-06 | Albireo Ab | Benzothia(di)azepine compounds and their use as bile acid modulators |
TW202015699A (zh) | 2018-06-05 | 2020-05-01 | 瑞典商艾爾比瑞歐公司 | 苯并噻(二)氮呯(benzothia(di)azepine)化合物及其作為膽汁酸調節劑之用途 |
WO2019245449A1 (en) | 2018-06-20 | 2019-12-26 | Albireo Ab | Pharmaceutical formulation of odevixibat |
US11801226B2 (en) | 2018-06-20 | 2023-10-31 | Albireo Ab | Pharmaceutical formulation of odevixibat |
CN108578376A (zh) * | 2018-07-27 | 2018-09-28 | 广州柏赛罗药业有限公司 | 性能改善的缓释微丸组合物 |
US11549878B2 (en) | 2018-08-09 | 2023-01-10 | Albireo Ab | In vitro method for determining the adsorbing capacity of an insoluble adsorbant |
US10722457B2 (en) | 2018-08-09 | 2020-07-28 | Albireo Ab | Oral cholestyramine formulation and use thereof |
US11007142B2 (en) | 2018-08-09 | 2021-05-18 | Albireo Ab | Oral cholestyramine formulation and use thereof |
US10941127B2 (en) | 2019-02-06 | 2021-03-09 | Albireo Ab | Benzothiadiazepine compounds and their use as bile acid modulators |
US10975045B2 (en) | 2019-02-06 | 2021-04-13 | Aibireo AB | Benzothiazepine compounds and their use as bile acid modulators |
IT201900013473A1 (it) * | 2019-07-31 | 2021-01-31 | Vetagro Int S R L | Composizioni comprendenti amminoacidi e un ulteriore componente per l'apporto di amminoacidi ad un animale monogastrico quale uomo o maiale |
IT201900013449A1 (it) * | 2019-07-31 | 2021-01-31 | Vetagro Int S R L | Composizione comprendente amminoacidi e una matrice lipidica per animali monogastrici non mammiferi e suo uso |
CN110917144A (zh) * | 2019-11-30 | 2020-03-27 | 江苏艾兰得营养品有限公司 | 一种骨架型维生素c缓释微丸及其制备方法 |
CA3158181A1 (en) | 2019-12-04 | 2021-06-10 | Albireo Ab | Benzothia(di)azepine compounds and their use as bile acid modulators |
JP2023504644A (ja) | 2019-12-04 | 2023-02-06 | アルビレオ・アクチボラグ | ベンゾチアジアゼピン化合物及び胆汁酸モジュレータとしてのそれらの使用 |
CA3158276A1 (en) | 2019-12-04 | 2021-06-10 | Per-Goran Gillberg | Benzothia(di)azepine compounds and their use as bile acid modulators |
US11014898B1 (en) | 2020-12-04 | 2021-05-25 | Albireo Ab | Benzothiazepine compounds and their use as bile acid modulators |
CR20220315A (es) | 2019-12-04 | 2022-10-26 | Albireo Ab | Compuestos de benzoti(di)azepina y su uso como moduladores del ácido biliar |
CN110898036A (zh) * | 2019-12-18 | 2020-03-24 | 乐普制药科技有限公司 | 一种熊去氧胆酸缓释肠溶胶囊及其制备方法 |
JP2023537285A (ja) | 2020-08-03 | 2023-08-31 | アルビレオ・アクチボラグ | ベンゾチア(ジ)アゼピン化合物及び胆汁酸モジュレータとしてのそれらの使用 |
KR20230106651A (ko) | 2020-11-12 | 2023-07-13 | 알비레오 에이비 | 진행성 가족성 간내 담즙정체증(pfic)을 치료하기 위한 오데빅시바트 |
EP4255565A1 (de) | 2020-12-04 | 2023-10-11 | Albireo AB | Benzothia(di)azepin-verbindungen und ihre verwendung als gallensäuremodulatoren |
GB2618161A (en) * | 2020-12-25 | 2023-11-01 | Nutriventia Ltd | Stable prolonged release formulation of vitamin C and A process for preparation thereof |
CN113791150B (zh) * | 2021-09-09 | 2023-08-11 | 浙江公正检验中心有限公司 | 一种用于动物源性食品中头孢类药物残留量的检测方法 |
Family Cites Families (47)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3908028A (en) * | 1973-04-19 | 1975-09-23 | Procter & Gamble | Soft drink composition containing paramethoxycinnamaldehyde as a flavoring agent and sweetner |
US4166107A (en) * | 1978-07-25 | 1979-08-28 | The United States Of America As Represented By The Secretary Of Agriculture | Sustained release bolus formulations containing insect growth regulators for control of livestock pests |
GB2209669B (en) | 1987-09-11 | 1992-02-12 | Squibb & Sons Inc | Pharmaceutical composition containing high drug load and method for preparing same |
US4761450A (en) * | 1987-12-11 | 1988-08-02 | Baychem International, Inc. | Compatible polymer blends useful as melt adhesives |
JP2760012B2 (ja) | 1988-12-26 | 1998-05-28 | 武田薬品工業株式会社 | 持続性細粒剤 |
JPH02193914A (ja) | 1989-01-23 | 1990-07-31 | Sumitomo Pharmaceut Co Ltd | マトリックス型持続性製剤 |
GB8913889D0 (en) | 1989-06-16 | 1989-08-02 | May & Baker Ltd | New compositions of matter |
WO1992012633A1 (en) * | 1991-01-16 | 1992-08-06 | Fmc Corporation | Carrier for active agents, and solid dosage forms prepared therewith |
US5580578A (en) | 1992-01-27 | 1996-12-03 | Euro-Celtique, S.A. | Controlled release formulations coated with aqueous dispersions of acrylic polymers |
BR9206996A (pt) | 1991-12-30 | 1995-12-05 | Fmc Corp | Composição adequada para preparar esferóides por esferoidização processo para produzir um material em partículas processo para produzir uma forma de dosagem de sólido esferoidizado em partículas e forma de dosagem sólida |
SE9200858L (sv) * | 1992-03-20 | 1993-09-21 | Kabi Pharmacia Ab | Metod för framställning av pellets med fördröjd frisättning |
US5700485A (en) | 1992-09-10 | 1997-12-23 | Children's Medical Center Corporation | Prolonged nerve blockade by the combination of local anesthetic and glucocorticoid |
IL119660A (en) | 1993-05-10 | 2002-09-12 | Euro Celtique Sa | Controlled release formulation comprising tramadol |
US5582351A (en) * | 1993-08-09 | 1996-12-10 | Tsau; Josef | Convenient to use aspartame and method of making |
JP3776941B2 (ja) | 1993-12-24 | 2006-05-24 | 塩野義製薬株式会社 | 味覚の改善された顆粒剤及びその製造方法 |
DE4413350A1 (de) * | 1994-04-18 | 1995-10-19 | Basf Ag | Retard-Matrixpellets und Verfahren zu ihrer Herstellung |
US5582855A (en) | 1994-07-01 | 1996-12-10 | Fuisz Technologies Ltd. | Flash flow formed solloid delivery systems |
FR2742659B1 (fr) | 1995-12-22 | 1998-03-13 | Pf Medicament | Procede de fabrication de minispheres matricielles a liberation prolongee |
DE19630035A1 (de) | 1996-07-25 | 1998-01-29 | Asta Medica Ag | Tramadol Multiple Unit Formulierungen |
FR2752732B1 (fr) | 1996-08-28 | 1998-11-20 | Pf Medicament | Forme galenique a liberation prolongee de milnacipran |
AU5200098A (en) | 1996-11-01 | 1998-05-29 | Ilex Oncology, Inc. | Sustained release formulation containing dfmo |
CA2282531A1 (en) * | 1997-03-25 | 1998-10-01 | Takeda Chemical Industries, Ltd. | Gastrointestinal mucosa-adherent pharmaceutical composition |
DE69939485D1 (de) * | 1998-11-12 | 2008-10-16 | Smithkline Beecham Plc | Arzneimittel zur gesteuerten freisetzung eines insulin sensibilisators und metformin |
US6673367B1 (en) * | 1998-12-17 | 2004-01-06 | Euro-Celtique, S.A. | Controlled/modified release oral methylphenidate formulations |
US6294192B1 (en) * | 1999-02-26 | 2001-09-25 | Lipocine, Inc. | Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents |
AP2002002410A0 (en) | 1999-08-04 | 2002-03-31 | Ranbaxy Laboratories Ltd | Hydrodynamically Balancing Oral Drug Delivery System |
US20030180352A1 (en) * | 1999-11-23 | 2003-09-25 | Patel Mahesh V. | Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
US6953593B2 (en) | 2000-02-01 | 2005-10-11 | Lipoprotein Technologies, Inc. | Sustained-release microencapsulated delivery system |
CN1423559A (zh) * | 2000-02-08 | 2003-06-11 | 欧罗赛铁克股份有限公司 | 包含阿片样激动剂和拮抗剂的控释组合物 |
US20020086070A1 (en) * | 2000-03-11 | 2002-07-04 | Kuhrts Eric Hauser | Anti-inflammatory and connective tissue repair formulations |
GB0013810D0 (en) * | 2000-06-06 | 2000-07-26 | Celltech Chiroscience Ltd | Biological products |
AU2001280597A1 (en) * | 2000-07-17 | 2002-01-30 | Guilford Pharmaceuticals Inc. | Compositions for sustained release of analgesic agents, and methods of making and using the same |
WO2002035991A2 (en) * | 2000-10-30 | 2002-05-10 | The Board Of Regents, The University Of Texas System | Spherical particles produced by a hot-melt extrusion/spheronization process |
US6620611B2 (en) * | 2001-01-06 | 2003-09-16 | Geovation Technologies, Inc. | Solid-chemical composition for sustained release of organic substrates and complex inorganic phosphates for bioremediation |
MXPA02009478A (es) | 2001-01-31 | 2003-03-10 | Roehm Gmbh | Forma medicinal de multiples particulas que comrpende por lo menos dos formas de bolitas recubiertas de diferente manera. |
US6669955B2 (en) * | 2001-08-28 | 2003-12-30 | Longwood Pharmaceutical Research, Inc. | Combination dosage form containing individual dosage units of a cholesterol-lowering agent, an inhibitor of the renin-angiotensin system, and aspirin |
DE10149674A1 (de) * | 2001-10-09 | 2003-04-24 | Apogepha Arzneimittel Gmbh | Orale Darreichungsformen für Propiverin oder seinen pharmazeutisch annehmbaren Salzen mit verlängerter Wirkstoffreisetzung |
DE60222160T2 (de) | 2001-10-12 | 2008-06-12 | Elan Pharma International Ltd., Athlone | Zusammensetzungen mit einer kombination aus eigenschaften sofortiger freisetzung und kontrollierter freisetzung |
WO2004002398A2 (en) | 2002-06-27 | 2004-01-08 | Cilag Ag | Spherical pellet containing a water-soluble active ingredient |
JP2004024686A (ja) | 2002-06-27 | 2004-01-29 | Nippon Shinyaku Co Ltd | 医薬ワックスマトリックスの製法 |
CN1201736C (zh) * | 2002-07-19 | 2005-05-18 | 安徽省药物研究所 | 甲硝唑结肠定位缓释制剂 |
US20040208936A1 (en) * | 2002-07-22 | 2004-10-21 | Roland Chorin | Novel compositions |
TWI357815B (en) * | 2003-06-27 | 2012-02-11 | Euro Celtique Sa | Multiparticulates |
US20050048118A1 (en) * | 2003-07-25 | 2005-03-03 | Joan Cucala Escoi | Modified release venlafaxine hydrochloride tablets |
DE102005005446A1 (de) * | 2005-02-04 | 2006-08-10 | Grünenthal GmbH | Bruchfeste Darreichungsformen mit retardierter Freisetzung |
US6984403B2 (en) | 2003-12-04 | 2006-01-10 | Pfizer Inc. | Azithromycin dosage forms with reduced side effects |
WO2005055972A2 (en) * | 2003-12-09 | 2005-06-23 | Nanon A/S | A drug delivery device and a method of producing it |
-
2008
- 2008-02-29 US US12/040,443 patent/US10888521B2/en active Active
- 2008-02-29 AU AU2008223091A patent/AU2008223091B2/en not_active Ceased
- 2008-02-29 EP EP08743631A patent/EP2144599B1/de not_active Not-in-force
- 2008-02-29 DE DE602008002073T patent/DE602008002073D1/de active Active
- 2008-02-29 WO PCT/US2008/055534 patent/WO2008109462A2/en active Application Filing
- 2008-02-29 CN CN2008800068721A patent/CN101652128B/zh active Active
- 2008-02-29 JP JP2009551878A patent/JP5452236B2/ja not_active Expired - Fee Related
- 2008-02-29 ES ES08743631T patent/ES2350029T3/es active Active
- 2008-02-29 AT AT08743631T patent/ATE476176T1/de not_active IP Right Cessation
- 2008-02-29 CA CA2678367A patent/CA2678367C/en active Active
-
2010
- 2010-08-16 HK HK10107807.6A patent/HK1141441A1/xx not_active IP Right Cessation
-
2013
- 2013-11-08 JP JP2013231841A patent/JP2014055158A/ja active Pending
-
2015
- 2015-06-10 JP JP2015117498A patent/JP2016000728A/ja active Pending
-
2020
- 2020-12-18 US US17/126,748 patent/US20210113469A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
HK1141441A1 (en) | 2010-11-12 |
JP5452236B2 (ja) | 2014-03-26 |
US20080220079A1 (en) | 2008-09-11 |
CA2678367C (en) | 2014-07-08 |
AU2008223091A1 (en) | 2008-09-12 |
DE602008002073D1 (de) | 2010-09-16 |
CN101652128B (zh) | 2012-12-19 |
EP2144599B1 (de) | 2010-08-04 |
US10888521B2 (en) | 2021-01-12 |
US20210113469A1 (en) | 2021-04-22 |
WO2008109462A2 (en) | 2008-09-12 |
AU2008223091B2 (en) | 2014-04-24 |
CN101652128A (zh) | 2010-02-17 |
CA2678367A1 (en) | 2008-09-12 |
WO2008109462A3 (en) | 2008-12-24 |
JP2016000728A (ja) | 2016-01-07 |
JP2010520226A (ja) | 2010-06-10 |
EP2144599A2 (de) | 2010-01-20 |
ES2350029T3 (es) | 2011-01-17 |
JP2014055158A (ja) | 2014-03-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE476176T1 (de) | Wachsähnliches material enthaltende tabletten mit verzögerter freisetzung | |
CY1118040T1 (el) | Συνθεσεις για πνευμονικη απελευθερωση μακροχρονιως-δρωντων μουσκαρινικων ανταγωνιστων και μακροχρονιως-δρωντων αγωνιστων β2 αδρενεργικων υποδοχεων και συσχετιζομενες μεθοδοι και συστηματα | |
FR2949062B1 (fr) | Nouvelles formulations pharmaceutiques contre le mesusage des medicaments | |
ECSP077999A (es) | Formulaciones de una sal de bupropion de liberación modificada | |
WO2009117130A3 (en) | Extended release forumulation containing a wax | |
ECSP088560A (es) | Formulacion de liberacion sostenida que comprende octreotida y dos o mas polimeros de polilactido-co-glicolido | |
MX2009000320A (es) | Formulaciones de liberacion controlada. | |
CR11740A (es) | Composiciones que comprenden fármacos levemente básicos y formas de dosificación de liberación controlada | |
MY149623A (en) | Sprayable gel-type skin/mucosa-adhesive preparation and administration system using the preparation | |
ZA200809864B (en) | Pharmaceutical formulations for the sustained release of active ingredients(s), as well as their applications, especially therapeutic | |
RS52169B (en) | STABLE LAKVINIMOD PREPARATIONS | |
ATE458486T1 (de) | Feste, oral applizierbare pharmazeutische darreichungsformen enthaltend rivaroxaban mit modifizierter freisetzung | |
RS50812B (sr) | Suva granulisana kompozicija koja sadrži emtricitabin i tenofovir df | |
AR082493A1 (es) | Formulaciones a base de nalbufina, y sus utilizaciones | |
WO2004112756A8 (en) | Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient | |
TR201902010T4 (tr) | Bir ajanın oral alımına yönelik taşıyıcı cihaz. | |
ECSP099463A (es) | Agentes para combatir parásitos en animales | |
ZA200900929B (en) | Microparticles based on an amphiphilic copolymer and on active ingredient(s) with modified release and pharmaceutical formulations containing same | |
ATE530170T1 (de) | Paliperidonformulierung mit verzögerter freisetzung | |
BRPI0814891A2 (pt) | Composição farmacêutica contendo composto oticamente ativo tendo atividade agonista de receptor de trombopoietina, e intermediário do mesmo. | |
CR20150266A (es) | Formulaciones de liberación modificada para oprozomib | |
EA201400737A1 (ru) | Система доставки на основе множества пеллет с немедленным высвобождением активного вещества | |
MX2012013021A (es) | Formulaciones resistentes a alcohol. | |
TR201819108T4 (tr) | Kontrollü salımlı matrisli farmasötik dozaj formülasyonu. | |
MX2007013327A (es) | Formulaciones de liberacion prolongada. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |